Decker Mark Okey Jr

CEO Decker Mark Okey Jr. purchases 5,000 shares for $169,700 as stock trades below 52-week highs; part of cluster with two other insiders buying within 14 days.

CEO and President Decker Mark Okey Jr. purchased 5,000 shares on a single day, adding meaningfully to his position while the stock trades below its 52-week high and has declined over the past month. This purchase is part of a broader wave in which two other insiders bought within the same 14-day window, creating a concentrated buying signal at a time when price weakness could have deterred action. Notably, the CEO has a track record of open-market purchases spanning the prior three years, with only one prior sale over the same period—a pattern of net accumulation. The company itself is profitable with growing revenue, and the CEO is buying into fundamentals that remain intact despite the recent price pullback. The combination of a repeat buyer adding shares during weakness, within a window where multiple insiders are also purchasing, raises the filing above routine executive activity.

CEO Mark Okey Jr. purchases 10,000 GMRE shares at $32.51; prior six-month buys averaged +386.5% over 90 days.

Mark Okey Jr., CEO and President of Global Medical REIT Inc., purchased 10,000 shares at $32.51 on 2025-12-05, increasing his holdings by 22.3% to 54,774 shares. His prior five trades at this same ticker—all purchases across the last six months—show a 100% win rate at the 90-day mark, with three measurable outcomes averaging +386.0% (the 2025-08-15 and 2025-06-25 purchases returned +369.6%, +367.5%, and +449.6% respectively). The current stock price of $32.84 is 27.7% below the 52-week high, having declined 13.0% over the past 90 days; this acquisition follows the company's recent quarterly report showing net losses of $-5.1M against $37.2M revenue, negative annual revenue growth of -1.6%, and an elevated P/E of 205.25. The timing and scale of this purchase—executed within three weeks of two prior acquisitions and at a price near recent lows—align with his historical pattern of accumulating at inflection points in GMRE's price action.

CEO Mark Okey Jr bought 10,000 shares at $32.58 blended avg, raising stake 28.8% to 44.8K shares; perfect 100% 90-day timing on all 5 prior GMRE trades.

Mark Okey Jr, CEO and President, executed 2 separate purchases totaling 10,000 shares (10.0K shares) for $325,813.03 ($325.8K) on 2025-11-14, increasing his post-transaction holdings to 44,774 shares (44.8K shares), a net increase of 10,000 shares (+28.8% vs pre-transaction holdings). This represents a significant capital commitment from the chief executive during a period when the stock trades 28.9% below its 52-week high of $45.40 and the company reports negative net income of $-5,058,000.00 ($-5.1M) in the latest quarter. Notably, Okey's prior 5 trades at GMRE share a consistent execution pattern: all 5 prior buys demonstrated positive 90-day returns ranging from 369.6% to 459.9%, establishing a 100% timing success rate at this ticker. His cross-ticker track record across all open-market history shows 9 prior buys with a 100.00% 90-day win rate, averaging 343.4% returns—indicating sustained execution discipline in identifying entry points before subsequent upward price movement.

GMRE CEO purchases 30.9K shares ($211.8K) at $6.84–$6.87 on 2025-08-15; stock now $33.30, 52-week high $50.80.

On 2025-08-15, Decker Mark Okey Jr, CEO and President of Global Medical REIT Inc., executed 2 separate open-market purchases totaling 30,894 shares for $211,825.65 at a blended average price of $6.86, increasing his holdings by 19.3% from 160,000 shares to 190,894 shares. The current stock price is $33.30, reflecting a -34.4% decline from the 52-week high of $50.80 and a -7.2% drop over the prior 30 days. Notably, Okey's prior 5 trades at GMRE (all in June 2025) showed extraordinary 30-day returns of +421.1% to +451.8%, though 90-day outcome measurement is not yet available for those positions. His cross-ticker track record spans 7 prior buys with an average 30-day return of +309.5% and a 100% 90-day win rate, though no prior cross-ticker buys achieved well-timed status at the 90-day mark. The current acquisition at materially depressed pricing relative to recent highs, combined with the CEO's substantial holdings increase and his demonstrated pattern of favorable near-term outcomes at this ticker, warrants investor attention to near-term price recovery dynamics and any forthcoming operational announcements from Global Medical REIT.

CEO Mark Okey Jr purchases 160,000 shares at blended $6.52 for $1.0M, first open-market accumulation in holding history.

Mark Okey Jr, CEO and President of Global Medical REIT Inc., executed 5 separate purchases totaling 160,000 shares for $1,042,527.98 across June 24–25, 2025, at an average price of $6.52 per share—establishing a new open-market position where he previously held zero shares. The transaction occurred when the stock was trading 35.9% below its 52-week high of $50.80 and represented a significant capital commitment by the company's top executive. Okey's cross-ticker track record shows 2 prior buys with a 90-day win rate of 100.00% and an average 90-day return of +8.7%, though this is his first measurable accumulation at GMRE specifically. The purchase timing coincides with a -25.1% 90-day decline and a 30-day recovery of +5.0%, creating a noteworthy asymmetry: the CEO is entering a substantial position after material recent losses but from a valuation that remains deeply depressed relative to prior highs.